Stelara and Glossitis - a phase IV clinical study of FDA data
Glossitis is found among people who take Stelara, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Stelara and have Glossitis. It is created by eHealthMe based on reports of 75,716 people who have side effects when taking Stelara from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
75,716 people reported to have side effects when taking Stelara.
Among them, 8 people (0.01%) have Glossitis.
What is Stelara?
Stelara has active ingredients of ustekinumab. It is often used in psoriasis. eHealthMe is studying from 76,023 Stelara users for its effectiveness, alternative drugs and more.
What is Glossitis?
Glossitis (infection of tongue with soreness) is found to be associated with 1,276 drugs and 803 conditions by eHealthMe.
Number of Stelara and Glossitis reports submitted per year:
Time on Stelara when people have Glossitis *:
- < 1 month: 33.33 %
- 1 - 6 months: 33.33 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 33.33 %
- 10+ years: 0.0 %
Gender of people who have Glossitis when taking Stelara *:
- female: 75 %
- male: 25 %
Age of people who have Glossitis when taking Stelara *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 12.5 %
- 50-59: 50.0 %
- 60+: 37.5 %
Common drugs people take besides Stelara *:
- Zyrtec: 1 person, 12.50%
- Methotrexate: 1 person, 12.50%
- Isoniazid: 1 person, 12.50%
- Cosentyx: 1 person, 12.50%
Common side effects people have besides Glossitis *:
- Lower Respiratory Tract Infection: 3 people, 37.50%
- Tumor: 3 people, 37.50%
- Sinus Pain: 3 people, 37.50%
- Pruritus Genital (uneasy irritation of the skin of the vagina and the surrounding area): 3 people, 37.50%
- Itching: 3 people, 37.50%
- Infusion Related Reaction: 3 people, 37.50%
- Indigestion: 1 person, 12.50%
- Carbuncle (a carbuncle is an abscess larger than a boil): 1 person, 12.50%
- Constipation: 1 person, 12.50%
- Furuncle (infection of the hair follicle): 1 person, 12.50%
Common conditions people have *:
- Thyroid Diseases: 1 person, 12.50%
- Abdominal Pain Upper: 1 person, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Stelara and have Glossitis?Check whether Glossitis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Glossitis and when was it recovered:
Expand to all the drugs that have ingredients of ustekinumab:
Alternative drugs to, pros and cons of Stelara:
- Stelara (76,023 reports)
Common Stelara side effects:
Browse all side effects of Stelara:a b c d e f g h i j k l m n o p q r s t u v w x y z
Glossitis treatments and more:
- Glossitis (4,831 reports)
COVID vaccines that are related to Glossitis:
- Glossitis in Moderna COVID Vaccine
- Glossitis in Pfizer BioNTech Covid Vaccine
- Glossitis in Johnson and Johnson Covid Vaccine
Common drugs associated with Glossitis:
All the drugs that are associated with Glossitis:
- Glossitis (1,276 drugs)
Common conditions associated with Glossitis:
All the conditions that are associated with Glossitis:
- Glossitis (803 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ustekinumab (the active ingredients of Stelara) and Stelara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Risperdal and Suicidal Ideation - 15 seconds ago
- Sulfacetamide Sodium and Angina Pectoris Aggravated - 33 seconds ago
- Vitamin B12 and Delirium - 36 seconds ago
- Ampyra and Multiple Fractures - 38 seconds ago
- Sulfasalazine and Desonide drug interaction - 44 seconds ago
- Botox and Diarrhea Haemorrhagic - 54 seconds ago
- Lonox and Symbicort drug interaction - 58 seconds ago
- Profen and Fluphenazine Decanoate drug interaction - a minute ago
- Metronidazole and Joint Swelling - a minute ago
- Coconut Oil and Pneumonia - a minute ago